PEAK6’s Insulet PODD Stock Holding History

PEAK6’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2	Closed	-$625	–	3273
2025 Q3	$587	Hold	2	–	–	﹤0.01%	2842
2025 Q2	$606	Sell	2 -1	-33%	-$289	﹤0.01%	2881
2025 Q1	$769	Buy	+3	New	+$812	﹤0.01%	2877

Other funds holding PODD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

PEAK6's PODD Position: Q4 2025 in Review

PEAK6 sold out of Insulet (PODD) in Q4 2025, closing a stake of 2 shares — an estimated $625 sold.

PEAK6 first reported a position in PODD in Q1 2025 and held it in 3 quarters. The position peaked at $769 in Q1 2025. 832 funds tracked by Wall St. Rank hold PODD as of Q4 2025.

PEAK6 reported no remaining Insulet position as of Q4 2025 after selling out during the quarter.
PEAK6 sold 2 Insulet shares in Q4 2025, an estimated $625.
PEAK6 first reported a position in Insulet in Q1 2025 and held it in 3 quarters.
PEAK6's Insulet position peaked at $769 in Q1 2025.
832 funds tracked by Wall St. Rank held Insulet as of Q4 2025.

Based on PEAK6's 13F filing for Q4 2025, filed 13 Feb 2026.